1.
Glenda J. Dickson, Fabio G. Liberante, Laura M Kettyle, Kathleen A. O’Hagan, Damian P. J. Finnegan, Lars Bullinger, Dirk Geerts, Mary Frances McMullin, Terry R. J. Lappin, Ken I. Mills, Alexander Thompson. HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy. haematol [Internet]. 2013Jul.31 [cited 2024Dec.18];98(8):1216-25. Available from: https://haematologica.org/article/view/6746